1. Home
  2. NEOG vs EVO Comparison

NEOG vs EVO Comparison

Compare NEOG & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEOG
  • EVO
  • Stock Information
  • Founded
  • NEOG 1981
  • EVO 1993
  • Country
  • NEOG United States
  • EVO Germany
  • Employees
  • NEOG N/A
  • EVO N/A
  • Industry
  • NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEOG Health Care
  • EVO Health Care
  • Exchange
  • NEOG Nasdaq
  • EVO Nasdaq
  • Market Cap
  • NEOG 1.3B
  • EVO 1.2B
  • IPO Year
  • NEOG 1989
  • EVO 2021
  • Fundamental
  • Price
  • NEOG $5.95
  • EVO $3.93
  • Analyst Decision
  • NEOG Buy
  • EVO Strong Buy
  • Analyst Count
  • NEOG 4
  • EVO 1
  • Target Price
  • NEOG $8.33
  • EVO $7.00
  • AVG Volume (30 Days)
  • NEOG 7.4M
  • EVO 50.6K
  • Earning Date
  • NEOG 10-09-2025
  • EVO 11-05-2025
  • Dividend Yield
  • NEOG N/A
  • EVO N/A
  • EPS Growth
  • NEOG N/A
  • EVO N/A
  • EPS
  • NEOG N/A
  • EVO N/A
  • Revenue
  • NEOG $886,886,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • NEOG N/A
  • EVO N/A
  • Revenue Next Year
  • NEOG $2.17
  • EVO $10.78
  • P/E Ratio
  • NEOG N/A
  • EVO N/A
  • Revenue Growth
  • NEOG N/A
  • EVO N/A
  • 52 Week Low
  • NEOG $3.87
  • EVO $2.84
  • 52 Week High
  • NEOG $16.79
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • NEOG 53.01
  • EVO 57.96
  • Support Level
  • NEOG $5.77
  • EVO $3.81
  • Resistance Level
  • NEOG $7.17
  • EVO $3.95
  • Average True Range (ATR)
  • NEOG 0.36
  • EVO 0.08
  • MACD
  • NEOG 0.01
  • EVO 0.01
  • Stochastic Oscillator
  • NEOG 32.43
  • EVO 78.26

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: